The Clorox Company currently trades at a relatively low forward P/E of 14x and offers a 6% dividend yield, making it attractive on the surface. However, the company faces near-term challenges including inflationary pressures, weak volume growth, and risks related to integrating its GOJO acquisition. While the outlook for fiscal year 2027 is more positive, a full turnaround is expected to take 12 to 24 months. Investors should expect minimal dividend growth until operational improvements and cost synergies materialize, though the dividend remains well-covered and share buybacks continue.
Clorox's slow recovery story is reflected in its current trading on Pluang, where the stock is priced at USD 81.15 and has seen a 3.16% drop in one day as of September 28, 2026, 22:41 WIB. The dividend yield remains attractive at 5.97%, close to the 6% mentioned, while the market cap stands at $10.13 billion. Investors typically hold the stock for about 97 days on the platform, indicating moderate-term interest despite the challenges.
Kimberly-Clark and Clorox both offer dividend yields above 4.5%, but Kimberly-Clark's payout appears safer due to its longer dividend increase streak, lower debt, and free cash flow nearly covering dividends. Clorox faces challenges with declining ma...
Clorox offers a nearly 6% dividend yield, appealing for income investors, but its falling stock price, shrinking cash flow, and high debt raise concerns about dividend safety. In contrast, Colgate-Palmolive provides a lower 2.27% yield but boasts str...
